Nonalcoholic fatty liver disease and diabetes

doi:10.4239/wjd.v13.i9.668

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6934)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

423

WORD

HTML

4370

Figures (1-3)

450

Tables (1-1)

309

Sum=5632

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

422

Download

880

Sum=1302

Sep 15, 2022 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Sep 15, 2022; 13(9): 668-682
Published online Sep 15, 2022. doi: 10.4239/wjd.v13.i9.668

Full Size Figure Download Figure

Figure 1 Pathogenesis and evolution of nonalcoholic fatty liver disease. FFA: Fatty free acids; HCC: Hepatocellular carcinoma; ROS: Reactive oxygen species; VLDL: Very low-density lipoprotein.

Citation: Bellini MI, Urciuoli I, Del Gaudio G, Polti G, Iannetti G, Gangitano E, Lori E, Lubrano C, Cantisani V, Sorrenti S, D’Andrea V. Nonalcoholic fatty liver disease and diabetes. World J Diabetes 2022; 13(9): 668-682
URL: https://www.wjgnet.com/1948-9358/full/v13/i9/668.htm
DOI: https://dx.doi.org/10.4239/wjd.v13.i9.668